Purchase Order 75F40120P00388
Award Date 7/14/20
Potential Completion Date 1/15/21
Potential Value $2.2M
Federal Agency
Ultimate Awardee
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- McKinsey & Company, Inc. was awarded a $6.95 million firm fixed price purchase order by the Department of Health and Human Services' Food and Drug Administration to provide COVID-19 central coordination support services. The contract has a period of performance from April 10, 2020 through March 11, 2021 and will be performed in Silver Spring, Maryland. As the current pandemic requires a coordinated response, this award likely seeks consulting support to help streamline FDA processes and...
- This federal contract award, valued at $477,346.58, was issued by the Food and Drug Administration (FDA) to the management consulting firm McKinsey & Company, Inc. Washington D.C. The contract is a Blanket Purchase Agreement (BPA) call under the General Services Administration's (GSA) Professional Services Schedule (PSS), with a firm fixed price pricing type. The contract is for organizational assessment services, with a period of performance ending on December 23, 2016. This award does...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price contract to McKinsey & Company, Inc. Washington D.C. for OCP Auditing Strategic Analysis and Roadmapping to Support Combination Products. The $1,969,083.75 contract, which was not set aside, was issued under the General Services Administration's Professional Services Schedule. McKinsey, a management consulting firm, has received over $500 million in federal contracts since 2008 to provide...
- The Department of Health and Human Services Food and Drug Administration awarded a Firm Fixed Price contract to McKinsey & Company, Inc. Washington D.C. to support the FDA's OMPT Modernization Efforts and Reorganization Initiatives. The $1,513,559.55 contract, awarded on December 12, 2017, was issued under the General Services Administration's Professional Services Schedule (PSS). The contract, which has a completion date of May 16, 2018, does not have a set-aside designation. McKinsey &...
- This is a federal contract award made by the Food and Drug Administration (FDA) to McKinsey & Company, Inc. Washington D.C., a global management consulting firm. The contract, valued at $1,647,674.58, is for strategic portfolio management consulting services to support the Center for Drug Evaluation and Research (CDER) Office of Management (OM). The contract is a Blanket Purchase Agreement (BPA) call order under the General Services Administration's (GSA) Professional Services Schedule...
- The Department of Health and Human Services Food and Drug Administration awarded a $4,328,544.04 firm fixed-price contract to McKinsey & Company, Inc. Washington D.C. to support the Center for Drug Evaluation and Research's New Drugs Regulatory Program Modernization initiative. The contract, which falls under the General Services Administration's Professional Services Schedule, requires McKinsey to prepare, design, and implement solutions to modernize the FDA's new drug regulatory processes....
- The Department of Health and Human Services Food and Drug Administration awarded a Firm Fixed Price contract to McKinsey & Company, Inc. Washington D.C. to provide assessment and evaluation services for the FDA's Expanded Access and Compassionate Use Programs. The contract, which was issued under the Professional Services Schedule (PSS) indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle, has a potential value of $764,125.32 and a completion date of May 15, 2018. McKinsey &...
- This is a firm fixed price BPA call contract awarded by the Food and Drug Administration (FDA) to McKinsey & Company, Inc. Washington D.C. for $1,493,644.43 to support the modernization of new drug reviews for the Center for Drug Evaluation and Research (CDER). The contract is under the GSA Professional Services Schedule (PSS) contract vehicle and has no set-aside designation. McKinsey & Company, a global management consulting firm, will provide strategic advisory services to the FDA...
- This federal contract was awarded by the Defense Health Agency (DHA) to McKinsey & Company, Inc. Washington D.C., a global management consulting firm, to provide COVID-19 testing strategies support activities. The contract is a definitive, firm-fixed-price contract with a ceiling value of $6,100,000.00 and a period of performance ending on April 27, 2021. The contract is not set aside for any socioeconomic category. McKinsey & Company, Inc. is the prime contractor and may utilize...
- The U.S. Department of Health and Human Services' Food and Drug Administration (FDA) awarded a firm fixed-price Blanket Purchase Agreement (BPA) call to McKinsey & Company, Inc. Washington D.C., a management consulting firm, for the "CDER Integrated Sentinel Strategy & Operational Plan" project. The $960,839.38 contract, which has a completion date of August 31, 2018, was not set aside for any specific business type. The contract work was performed in Silver Spring, Maryland...